Results of a Phase 2 Clinical Trial Using Technology Developed at Northwestern Medicine for the Treatment of Celiac Disease Look Promising!

“Results of a new phase 2 clinical trial using technology developed at Northwestern Medicine show it is possible to induce immune tolerance to gluten in individuals with celiac disease. The findings may pave the way for treated celiac patients to eventually tolerate gluten in their diet.  After treatment with the technology, the patients were able […] read more

On October 25th, 2019, posted in: CeliacCorner Blogs by ,